CTC Clinical Trial Consultants AB — Clinical Trial Site

67 Registered trials

11 Currently recruiting

Organisation

CTC Clinical Trial Consultants AB

Location

Uppsala, Sweden

Identifier

ORG-100028585

Address

Vetenskapens Graend 11, 431 53, Sweden

Departments

#7510
#7511
#7512
Akademiska sjukhuset
Clinical Trial Consultants AB
Clinical Trial Consultants AB, Dag Hammarskjöldsväg 14, 752 37 Uppsala
Clinical trials
CTC
CTC AB
CTC Akademiska
CTC Clinical Trial Consultants
CTC Clinical Trial Consultants AB
CTC Clinical Trial Consultants AB, CTC Karolinska
CTC Ebbe Park
CTC EbbePark Linköping
CTC Ebbepark, Linköping
CTC GoC Gothenburg
CTC GoCo
CTC GoCO Molndal
CTC GoCo Möndal
CTC Karolinska
CTC Karolinska Stockholm
CTC MTC
CTC MTC, Uppsala
CTC Oscar
CTC Uppsala
Department Lung- och allergy diseases
Dermatology Department
Kardiologi
Lung- och allergimottagningen
Lungkliniken
MTC
N/A
NA
Uppsala University Hospital

Clinical trials at this site (67)

Search interface

The Attractive 2 trial – An open-label, randomised, 2-period cross-over trial to assess the pharmacokinetics of ATR-258 oral capsule vs. ora… Ended

2023-508797-28-00 Type 2 diabetes (T2D) 3 2024-04-24
Safety and Immunogenicity of V116 in Children and Adolescents With Increased Risk for Pneumococcal Disease Ended

2023-506236-32-00 Pneumococcal disease 5 2024-03-25
A24110He in a placebo-controlled trial evaluating safety in subjects with elevated plasma triglycerides Ended

2023-509091-42-00 Moderate to severe hypertriglyceridemia 4 2024-02-27
A phase 1, randomised, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study to evaluate the safety, tol… Ended

2023-506912-41-00 Idiopathic pulmonary fibrosis 3 2024-01-09
A randomised, placebo-controlled, double-blinded, cross-over, Phase 1 study evaluating the safety and preliminary efficacy of the GLP 1 anal… Ended

2023-507758-34-00 Overweight 3 2023-11-10
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight… Ended

2022-502678-18-00 Type 2 diabetes 5 2023-11-07
An open-label, healthy subject, two-part study to assess the effect of verapamil on systemic exposure of EP395 (Part A), and to assess the e… Ended

2023-506345-34-00 Chronic obstructive pulmonary disease (COPD) 3 2023-10-23
Control Of BioEquivalence with Xenical (COBEX): A Phase I, randomized, active-control study to evaluate EMP22 pharmacodynamics and EMP16 pha… Ended

2023-505671-74-00 Obesity 2 2023-09-22
A trial to evaluate safety and characteristics of a substance for treatment of chronic hepatitis Ended

2023-503880-40-00 Chronic hepatitis B 4 2023-09-19
A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PARALLEL AND PLACEBO-CONTROLLED SINGLE AND MULTIPLE ASCENDING DOSE TRIAL INVESTIGATING SAFETY, TOLERAB… Ended

2023-505280-36-00 Erectile dysfunction 1 2023-08-25
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended

2022-502234-70-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-07-14
C4951004 - BHV3000-406: A Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute … Ended

2024-513269-37-00 Migraine attacks with or without aura 6 2023-03-14
C4951012 - BHV3000-407: A Phase 4, Randomized, Double-blind, Placebo controlled Study to Evaluate the Efficacy and Tolerability of Rimegepan… Ended

2024-513270-21-00 migraine headaches with or without aura 6 2023-03-14
A study to evaluate the efficacy and safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 Ended

2023-504540-33-00 COVID-19 5 2023-03-06
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Ended

2024-510729-24-00 Chronic Migrane, Migrane, Medication Overuse Headache 6 2022-09-01
Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 5 2022-08-10
A study to evaluate ExPEC9V vaccine for the prevention of Invasive E. coli Disease in adults aged 60 years and older with a history of urina… Ended

2023-506589-30-00 Invasive Extraintestinal Pathogenic Escherichia coli Di 5 2022-02-09
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28